Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

PEA15 Protein, Human, Recombinant

SKU: orb1961202

Description

Astrocyticphosphoprotein PEA-15 (PEA15) is a death effector domain (DED)-containing protein. PEA15 is mainly expressed in the central nervous system, principally in astrocytes. Increased PEA15 levels affect tumorigenesis and cancer progression. PEA15 is overexpressed in breast cancers and gliomas as well as in type 2 diabetes. PEA15 blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. PEA15 also inhibits RPS6KA3 activities by holding it in the cytoplasm. In addition, PEA15 inhibits both TNFRSF6 and TNFRSF1A mediated CASP8 activity and apoptosis. At present, PEA15 expression is also a significant prognostic marker in ovarian cancer.

Research Area

,Recombinant-Protein

Images & Validation

Application Notes
Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.

Key Properties

Expression SystemE. coli
Biological OriginHuman
Biological ActivityAstrocyticphosphoprotein PEA-15 (PEA15) is a death effector domain (DED)-containing protein. PEA15 is mainly expressed in the central nervous system, principally in astrocytes. Increased PEA15 levels affect tumorigenesis and cancer progression. PEA15 is overexpressed in breast cancers and gliomas as well as in type 2 diabetes. PEA15 blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. PEA15 also inhibits RPS6KA3 activities by holding it in the cytoplasm. In addition, PEA15 inhibits both TNFRSF6 and TNFRSF1A mediated CASP8 activity and apoptosis. At present, PEA15 expression is also a significant prognostic marker in ovarian cancer.
TagTag Free
Expression RegionMet1-Ala130
MW12—16 KDa (reducing condition)
Purity98.00%
Protein SequenceMet1-Ala130

Storage & Handling

Storage-20°C
Expiration Date6 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Human PEA15 protein [orb54496]

    Greater than 90% as determined by SDS-PAGE.

    42 kDa

    E.coli

    20 μg, 100 μg, 1 mg
  • Human PEA15 protein [orb392266]

    ELISA,  MS,  SDS-PAGE,  WB

    Greater than 95% as determined by reducing SDS-PAGE.

    E. coli

    10 μg, 50 μg, 500 μg
  • Human PEA15 Protein [orb427604]

    Greater than 90.0% as determined by SDS-PAGE.

    Escherichia Coli

    2 μg, 10 μg, 1 mg
  • Recombinant Human PEA15 Protein, No Tag [orb1551863]

    ≥90% as determined by SDS-PAGE

    This protein contains the human PEA15(Met1-Ala130) was fused without Tag and expressed in E. coli.

    100 μg, 50 μg
  • Human PEA15 protein [orb163502]

    50 μg, 10 μg, 500 μg, 1 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

UniProt Details

No UniProt data available

Protocol Information

Protein Handling and Storage Guide
Protein Handling Guide
View Guide

Available Sizes

Select a size below

10 μg
$ 230.00
50 μg
$ 490.00
500 μg
$ 2,000.00
1 mg
$ 2,830.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry